125 related articles for article (PubMed ID: 9437242)
1. Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors.
de Keyzer Y; Lenne F; Bertagna X
Eur J Endocrinol; 1997 Dec; 137(6):715-8. PubMed ID: 9437242
[TBL] [Abstract][Full Text] [Related]
2. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
3. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
[TBL] [Abstract][Full Text] [Related]
4. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
6. Gene transcription of receptors for growth hormone-releasing peptide and somatostatin in human pituitary adenomas.
Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Astrup J; Weeke J; Jørgensen JO
J Clin Endocrinol Metab; 1998 Aug; 83(8):2997-3000. PubMed ID: 9709982
[TBL] [Abstract][Full Text] [Related]
7. In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression.
Machado MC; Sá SV; Goldbaum TS; Catania M; Campos VC; Corrêa-Giannella ML; Giannella-Neto D; Salgado LR
J Endocrinol Invest; 2007 Apr; 30(4):334-40. PubMed ID: 17556872
[TBL] [Abstract][Full Text] [Related]
8. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
Korbonits M; Bustin SA; Kojima M; Jordan S; Adams EF; Lowe DG; Kangawa K; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.
Pascual-Le Tallec L; Dulmet E; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 2002 Nov; 87(11):5015-22. PubMed ID: 12414866
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretagogue receptor expression in human pituitary tumors.
Skinner MM; Nass R; Lopes B; Laws ER; Thorner MO
J Clin Endocrinol Metab; 1998 Dec; 83(12):4314-20. PubMed ID: 9851770
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas.
Martínez-Fuentes AJ; Moreno-Fernández J; Vázquez-Martínez R; Durán-Prado M; de la Riva A; Tena-Sempere M; Diéguez C; Jiménez-Reina L; Webb SM; Pumar A; Leal-Cerro A; Benito-López P; Malagón MM; Castaño JP
J Clin Endocrinol Metab; 2006 Jun; 91(6):2225-31. PubMed ID: 16551736
[TBL] [Abstract][Full Text] [Related]
13. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
[TBL] [Abstract][Full Text] [Related]
15. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and non-endocrine activities of growth hormone secretagogues in humans.
Ghigo E; Arvat E; Broglio F; Giordano R; Gianotti L; Muccioli G; Papotti M; Graziani A; Bisi G; Deghenghi R; Camanni F
Horm Res; 1999; 51 Suppl 3():9-15. PubMed ID: 10592438
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome.
Giordano R; Picu A; Broglio F; Bonelli L; Baldi M; Berardelli R; Ghigo E; Arvat E
Pituitary; 2004; 7(4):243-8. PubMed ID: 16132204
[TBL] [Abstract][Full Text] [Related]
18. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells.
Adams EF; Huang B; Buchfelder M; Howard A; Smith RG; Feighner SD; van der Ploeg LH; Bowers CY; Fahlbusch R
J Clin Endocrinol Metab; 1998 Feb; 83(2):638-42. PubMed ID: 9467586
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
20. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
